Torge Rempe

Torge Rempe, MD

Assistant Professor

Department: MD-NEURO-MULTIPLE SCLEROSIS
Business Phone: (352) 294-5000
Business Email: torgerempe@ufl.edu

About Torge Rempe

Torge Rempe, M.D., went to medical school at the Christian-Albrechts-University of Kiel in Germany with one year at the University of Murcia in Spain with the LLP/Erasmus – grant. Afterwards, he began his German postgraduate neurologic training at the University Hospital of Kiel. During his training in Germany, he received the Sponsorship Award for Basic Pain Research 2014 of the German Association for the Study of Pain and the German doctorate degree with “magna cum laude”. After his preliminary year at SUNY Downstate Medical Center, Dr. Rempe completed his US neurology residency at the University of Florida. During his residency, he received the Program Director’s Award of Academic Excellence in three consecutive years and the Kenneth M. Heilman Award for Excellence in Research. In July 2020, he started his clinical neuroimmunology fellowship at UCSD with the National Multiple Sclerosis Society’s clinical care fellowship grant. He has many publications and has already had a prolific research career in Germany, at UF and at UCSD.

Publications

2021
Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Multiple sclerosis and related disorders. 48 [DOI] 10.1016/j.msard.2020.102718. [PMID] 33388560.
2021
CNS Lymphocytic Vasculitis in a Young Woman With COVID-19 Infection.
Neurology(R) neuroimmunology & neuroinflammation. 8(5) [DOI] 10.1212/NXI.0000000000001048. [PMID] 34321332.
2021
Quantification of smooth pursuit dysfunction in multiple sclerosis.
Multiple sclerosis and related disorders. 54 [DOI] 10.1016/j.msard.2021.103073. [PMID] 34214878.
2020
“Status myotonicus” in Nav1.4-M1592V channelopathy.
Neuromuscular disorders : NMD. 30(5):424-426 [DOI] 10.1016/j.nmd.2020.03.002. [PMID] 32327288.
2020
Anti-JCV antibody index does not change during ocrelizumab-treatment.
Multiple sclerosis journal – experimental, translational and clinical. 6(3) [DOI] 10.1177/2055217320960510. [PMID] 33029356.
2020
Corticosteroids lead to short-term improvement in cerebral amyloid angiopathy-related inflammation.
Journal of neuroimmunology. 348 [DOI] 10.1016/j.jneuroim.2020.577377. [PMID] 32919147.
2020
Dorsal Root Ganglion Stimulation as a Potentially Effective Treatment for Painful Hereditary and Idiopathic Axonal Polyneuropathy: A Retrospective Case Series.
Neuromodulation : journal of the International Neuromodulation Society. 23(2):234-238 [DOI] 10.1111/ner.12924. [PMID] 30762923.
2020
Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing.
Neurology(R) neuroimmunology & neuroinflammation. 7(3) [DOI] 10.1212/NXI.0000000000000709. [PMID] 32198230.
2019
A case of CLIPPERS syndrome responsive to tocilizumab.
Neurology(R) neuroimmunology & neuroinflammation. 6(3) [DOI] 10.1212/NXI.0000000000000545. [PMID] 30882019.
2019
Neurofascin-140 and -155 antibodies in an atypical case of poems syndrome.
Muscle & nerve. 60(1):E1-E3 [DOI] 10.1002/mus.26493. [PMID] 31018253.
2019
The spectrum of progressive multifocal leukoencephalopathy: a practical approach.
European journal of neurology. 26(4):566-e41 [DOI] 10.1111/ene.13906. [PMID] 30629326.
2016
Early-onset parkinsonism due to compound heterozygous POLG mutations.
Parkinsonism & related disorders. 29:135-7 [DOI] 10.1016/j.parkreldis.2016.04.020. [PMID] 27185166.
2016
Sensitization of the Nociceptive System in Complex Regional Pain Syndrome.
PloS one. 11(5) [DOI] 10.1371/journal.pone.0154553. [PMID] 27149519.
2015
Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.
Annals of neurology. 78(4):501-14 [DOI] 10.1002/ana.24471. [PMID] 26150206.
2015
Spinal and supraspinal processing of thermal stimuli: an fMRI study.
Journal of magnetic resonance imaging : JMRI. 41(4):1046-55 [DOI] 10.1002/jmri.24627. [PMID] 24737401.
2014
Spinal fMRI reveals decreased descending inhibition during secondary mechanical hyperalgesia.
PloS one. 9(11) [DOI] 10.1371/journal.pone.0112325. [PMID] 25372292.

Contact Details

Phones:
Business:
(352) 294-5000
Emails:
Business:
torgerempe@ufl.edu